Funders › CA › Concern Foundation › 2022
Grants paid by Concern Foundation, tax year 2022
EIN 23-7002878 · Los Angeles, CA · Form 990, Schedule I · NTEE T22Z
In tax year 2022, Concern Foundation (EIN 23-7002878) reported 17 grants paid totaling $925,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | University of Southern California Los Angeles, CA | C | $100,000 | paid | RESEARCH INTO ETHNIC DIFFERENCES AMONG BREAST CANCER PATIENT IMMUNE RESPONSES | 202332429349301353 |
| 2022 | University of Utah Salt Lake City, UT | B | $60,000 | paid | TENASCIN-C IN EARLY LUNG CANCER INVASION | 202332429349301353 |
| 2022 | The Lundquist Institute at Harbor-UCLA Medical Center Torrance, CA | U | $60,000 | paid | INVESTIGATING NOVEL SIGNALING CIRCUITS CONTROLLING PDL1 SURFACE LOCALIZATION IN CANCER CELLS. | 202332429349301353 |
| 2022 | Beckman Research Institute of City of Hope Duarte, CA | U | $60,000 | paid | TARGETING THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IN B CELL MALIGNANCIES | 202332429349301353 |
| 2022 | University of Michigan Ann Arbor, MI | U | $60,000 | paid | REGULATING JAK-STAT SIGNALING PATHWAYS TO ENHANCE T CELL IMMUNOTHERAPY | 202332429349301353 |
| 2022 | Purdue University West Lafayette, IN | B | $60,000 | paid | THE ROLE OF PP2A IN REGULATING PDAC METHUOSIS | 202332429349301353 |
| 2022 | Medical University of South Carolina Charleston, SC | C | $60,000 | paid | KRASG12R ALLELE-SPECIFIC METABOLIC REPROGRAMMING ALTERS THERAPEUTIC SENSITIVITY | 202332429349301353 |
| 2022 | The University of Illinois at Chicago Chicago, IL | U | $60,000 | paid | REGULATION OF MECHANOSURVEILLANCE BY K HANDLING DURING BREAST CANCER METASTASIS | 202332429349301353 |
| 2022 | Brigham and Women's Hospitalharvard Medical School Boston, MA | U | $60,000 | paid | OVERCOMING PARP INHIBITOR RESISTANCE BY MODULATING TUMOR ASSOCIATED MACROPHAGES TO ENHANCE T CELL ACTIVATION | 202332429349301353 |
| 2022 | Washington University School of Medicine in St Louis St Louis, MO | U | $60,000 | paid | INVESTIGATE THE TUMOR SUPPRESSIVE ROLE OF ARID HOMOLOGS IN MELANOMA | 202332429349301353 |
| 2022 | Nyu Grossman School of Medicine New York, NY | U | $60,000 | paid | DISCOVERING AND TARGETING COQ10 SYNTHESIS IN PANCREATIC CANCER | 202332429349301353 |
| 2022 | Children's Hospital Los Angeles Usc Los Angeles, CA | U | $60,000 | paid | FLIP-FLOPPING OF FUSION-POSITIVE RHABDOMYOSARCOMA LEADING TO METASTATIC INVASION | 202332429349301353 |
| 2022 | University of Southern California Los Angeles, CA | U | $55,000 | paid | LIQUID BIOPSY DATABASE CREATION | 202332429349301353 |
| 2022 | Beckman Research Institute of City of Hope Duarte, CA | U | $50,000 | paid | DISRUPTING METABOLIC ADAPTATION IN PANCREATIC CANCER THROUGH INTRATUMORAL HEPARAN SULFATE DEGRADATIOR | 202332429349301353 |
| 2022 | Sharsheret Teaneck, NJ | B | $25,000 | paid | QUALITY OF LIFE KITS AND THE BUSY BOXES | 202332429349301353 |
| 2022 | Children's Hospital Los Angeles Los Angeles, CA | U | $25,000 | paid | SUMMER STUDENT ONCOLOGY PROGRAM | 202332429349301353 |
| 2022 | Hope for Henry Foundation Washington, DC | B | $10,000 | paid | SUPER REWARDS FOR SUPER KIDS AT CHLA | 202332429349301353 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.